Spots Global Cancer Trial Database for nivolumab plus ipilimumab plus maraviroc
Every month we try and update this database with for nivolumab plus ipilimumab plus maraviroc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial | NCT04721301 | Colorectal Canc... Pancreatic Canc... | Nivolumab plus ... | 18 Years - | University Hospital Heidelberg | |
Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial | NCT04721301 | Colorectal Canc... Pancreatic Canc... | Nivolumab plus ... | 18 Years - | University Hospital Heidelberg | |
Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial | NCT04721301 | Colorectal Canc... Pancreatic Canc... | Nivolumab plus ... | 18 Years - | University Hospital Heidelberg |